Department News

Dr. Lon Schneider receives new $3.5 million RO1

Dr. Lon Schneider's most recent R01 is a 5-year, $3.5-million award from the National Institute of Aging (NIA) to assess the potential for an extended-release formulation of phenserine to inhibit preprogrammed neuron death in Alzheimer's disease (AD) using a Phase 1b ascending dose platform. Schneider and his co- investigators,… Read More »

Latest News

Search All News - 4 results

Dr. Lon Schneider receives new $3.5 million RO1

May 1st, 2019

Dr. Lon Schneider’s most recent R01 is a 5-year, $3.5-million award from the National Institute of Aging (NIA) to assess the potential for an extended-release formulation of phenserine to inhibit preprogrammed neuron… Read More »